|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenues | ||
| Revenues from underwriting modeling (ICE) | ||
| Revenues from fees | ||
| Total revenues | ||
| Cost of revenues | ||
| Gross profit | ||
| Operating expenses | ||
| Sales and marketing expenses | ||
| General and administrative expenses | ||
| Research and development expenses | ||
| Total operating expenses | ||
| Other income (expense): | ||
| Interest income | ||
| Other income | ||
| Other expense | ||
| Total other income (expense), net | ||
| Income before income tax expense | ||
| Provision for income taxes | ||
| Income from continuing operations, net of income taxes | ||
| Net income attributable to common stockholders | ||
| Net income | ||
| Net income per share*: | ||
| Continuing operations, basic (in Dollars per share) | ||
| Basic (in Dollars per share) | ||
| Common Stock | ||
| Total basic (in Dollars per share) | ||
| Continuing operations, diluted (in Dollars per share) | ||
| Diluted (in Dollars per share) | ||
| Common Stock | ||
| Total diluted (in Dollars per share) | ||
| Weighted average common stocks outstanding*: | ||
| Basic (in Shares) | ||
| Common Stock | ||
| Total basic (in Shares) | ||
| Diluted (in Shares) | ||
| Common Stock | ||
| Total diluted (in Shares) |
Loading...
